Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Case-Control Study
60%
Drug Utilization
54%
Malignant Neoplasm
35%
Antivitamin K
32%
Anticoagulant Agent
32%
Warfarin
31%
Prevalence
29%
Non-Steroidal Anti-Inflammatory Drug
29%
Statin (Protein)
26%
Prescription Drug
21%
SARS Coronavirus
21%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Hydrochlorothiazide
20%
Acetylsalicylic Acid
17%
Skin Cancer
17%
Comorbidity
17%
Antidepressant
17%
Atrial Fibrillation
16%
Melanoma
16%
Disease
16%
Cerebrovascular Accident
16%
Non Melanoma Skin Cancer
15%
Infection
15%
Proton Pump Inhibitor
15%
Defined Daily Dose
13%
Antibiotics
13%
Prostate Cancer
12%
Opiate
12%
Randomized Clinical Trial
12%
Phthalic Acid
12%
Paracetamol
11%
Attention Deficit Disorder
11%
Analgesic Agent
11%
Non Insulin Dependent Diabetes Mellitus
11%
Dipeptidyl Carboxypeptidase Inhibitor
10%
Adverse Outcome
10%
Direct Oral Anticoagulant
10%
Dicloxacillin
10%
Psychotropic Agent
10%
Asthma
10%
Drug-Drug Interaction
9%
Angiotensin Receptor Antagonist
9%
Chronic Obstructive Lung Disease
9%
Community Pharmacy
9%
Adverse Event
9%
All Cause Mortality
8%
Observational Study
8%
Ovary Cancer
8%
Squamous Cell Carcinoma
8%
Medicine and Dentistry
Cohort Analysis
70%
Odds Ratio
33%
Drug Therapy
32%
Case-Control Study
28%
Malignant Neoplasm
25%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Vitamin K Antagonist
21%
Antithrombotic
20%
Hazard Ratio
20%
Melanoma
19%
Infection
16%
Proton-Pump Inhibitor
15%
Drug Use
15%
Hydrochlorothiazide
14%
COVID-19
13%
Atrial Fibrillation
13%
Skin Cancer
12%
Nonsteroid Antiinflammatory Agent
12%
Adolescence
12%
Patient Registry
11%
Comorbidity
11%
Antibiotics
11%
Prevalence
11%
Cancer Risk
11%
Apoplexy
10%
Logistic Regression Analysis
9%
Maturity Onset Diabetes of the Young
9%
Non Melanoma Skin Cancer
9%
Health Care
9%
Prostate Cancer
9%
Pharmacoepidemiology
9%
Body Mass Index
8%
General Practitioner
8%
Adverse Outcome
8%
Cohort Effect
8%
Disease
8%
Prescription Drug
8%
Asthma
7%
Adverse Event
7%
Intensive Care Unit
7%
Observational Study
6%
Statin
6%
Histamine Antagonist
6%
Anodyne
6%
Systematic Review
6%
Obstetrics
6%
Benzodiazepine
6%
Bleeding
5%
Cardiovascular System
5%
Ovarian Cancer
5%
